Current state-of-the-art pharmacotherapy for the management of hepatitis B infection

Introduction: Hepatitis B virus (HBV) infection remains a global challenge with several hundred million infected individuals. Disease activity can be controlled, and adverse outcomes prevented when treatment can be provided. Frequently life-long therapy is required instead of defined treatment periods such as with the case of Hepatitis C Virus (HCV) infection.Areas covered: In this review, the authors provide an overview of current start of the...